Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Effects of acetazolamide combined with remote ischemic preconditioning on risk of acute mountain sickness: a randomized clinical trial

Fig. 3

Incidence and severity of AMS assessed using the 2018 Lake Louise Acute Mountain Sickness Score at 6 h of hypoxic exposure in different groups. a AMS incidence rates. b Lake Louise AMS Scores. Data presented as mean with SD. c Distribution of AMS Scores. The numbers within the bars represent the percentage of subjects with each score

Back to article page